L-carnitine and coenzyme Q10 protective action against ischaemia and reperfusion of working rat heart
Dual or Multi-Agonists (GLP-1 + GIP or GLP-1 + Glucagon) This treatment stimulates multiple metabolic hormone receptors at once, such as GIP (glucose-dependent insulinotropic polypeptide) in addition to GLP-1
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP1-RA) that is administered subcutaneously once weekly
Specific Evidence for No IGF-1 Effects: Blood samples collected at baseline and throughout the treatment period measured serum IGF-1 concentrations using validated immunoassays
1,4 Hyperglycemia, dyslipidemia, and insulin resistance activate various metabolic pathways, resulting in oxidative stress, mitochondrial dysfunction, inflammation, and microvascular damage, culminating in neuronal injury, Schwann cell damage, and myelin sheath degeneration
Dual vs